TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics
STOCKS

Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics

  • By Adam Feuerstein
  • Feb 8, 2013 6:30 AM EST
Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Biotech Stock Mailbag: Vical, Hep C Drugs

  • By Adam Feuerstein
  • Jan 27, 2012 7:00 AM EST
Pfizer to Buy King Pharma for $3.6B Cash
STOCKS

Biotech Sector Weekly Rewind

  • By Adam Feuerstein
  • Oct 9, 2010 8:00 AM EDT
STOCKS

Biotech Stock Mailbag: Generex

  • By Adam Feuerstein
  • Oct 1, 2010 7:00 AM EDT
STOCKS

Biotech Stock Mailbag: Spectrum Pharma

  • By Adam Feuerstein
  • Jun 18, 2010 7:00 AM EDT
STOCKS

Generex Plans Reverse Stock Split

  • By Adam Feuerstein
  • May 11, 2010 5:50 PM EDT
Duchenne Drug Developer (Not Sarepta) Hit With Lengthy FDA Delay
STOCKS

Biotech Stock Mailbag: AspenBio

  • By Adam Feuerstein
  • Apr 30, 2010 6:00 AM EDT
STOCKS

Generex Creates Own Regulatory Reality

  • By Adam Feuerstein
  • Apr 29, 2010 7:00 AM EDT
STOCKS

Generex: What Happens in India, Stays in India

  • By Adam Feuerstein
  • Apr 6, 2010 10:12 AM EDT
Germany Slaps PTC Therapeutics With Big Drug Price Cut
STOCKS

Biotech Stock Mailbag: Generex, Part II

  • By Adam Feuerstein
  • Mar 26, 2010 7:00 AM EDT
Duchenne Drug Developer (Not Sarepta) Hit With Lengthy FDA Delay
STOCKS

Biotech Stock Mailbag: Generex

  • By Adam Feuerstein
  • Mar 19, 2010 7:00 AM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Smart Modular, Cosan: Early Volume Plays

  • By Robert Holmes
  • Feb 1, 2010 9:21 AM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

Art Technology, Pacific Capital: Early Volume Plays

  • By Robert Holmes
  • Feb 1, 2010 7:26 AM EST
Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

Biotech Stock Mailbag: Chelsea Therapeutics

  • By Adam Feuerstein
  • Jul 10, 2009 8:00 AM EDT
Pfizer to Buy King Pharma for $3.6B Cash
STOCKS

Generex's Net Loss Widens On Interest Expense

  • By TheStreet Ratings
  • Jun 10, 2009 1:28 PM EDT
STOCKS

Generex Posts Net Loss in Second Quarter

  • By TheStreet Ratings
  • Mar 12, 2009 1:22 PM EDT
Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

Feuerstein's Biotech-Stock Mailbag

  • By Adam Feuerstein
  • Apr 19, 2008 9:00 AM EDT
INVESTING

Stockpickr Lists: Autodesk

  • By Stockpickr Staff
  • Jun 13, 2007 7:06 AM EDT
INVESTING

Tuesday's Health Winners & Losers

  • By Elizabeth Trotta
  • Jun 12, 2007 3:16 PM EDT
INVESTING

Thursday's Health Winners & Losers

  • By TSC Staff
  • Dec 14, 2006 10:18 AM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

SEC Sues Gryphon

  • By Matthew Goldstein
  • Dec 12, 2006 1:43 PM EST
INVESTING

Tuesday's Health Winners & Losers

  • By Althea Chang
  • Oct 10, 2006 1:58 PM EDT
STOCKS

Generex Biotech Rises on New Coverage

  • By TSC Staff
  • Sep 27, 2006 4:09 PM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Monday's Small-Cap Winners & Losers

  • By TSC Staff
  • Sep 18, 2006 2:33 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Monday's Health Winners & Losers

  • By TSC Staff
  • Jun 19, 2006 1:40 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.